In T2-T3 stage CRC, CD90+ CAFs are the main source of IL-6 in the tumor microenvironment and can promote the expression of stem cell markers ALDH and Lgr5 in cancer cells, thereby promoting cancer development (69). The gene discussed is LGR5; the disease is cancer.